CR20110461A - BIOMARCATOR FOR PATIENT MONITORING - Google Patents

BIOMARCATOR FOR PATIENT MONITORING

Info

Publication number
CR20110461A
CR20110461A CR20110461A CR20110461A CR20110461A CR 20110461 A CR20110461 A CR 20110461A CR 20110461 A CR20110461 A CR 20110461A CR 20110461 A CR20110461 A CR 20110461A CR 20110461 A CR20110461 A CR 20110461A
Authority
CR
Costa Rica
Prior art keywords
biomarcator
patient monitoring
immunotherapy
methods
field
Prior art date
Application number
CR20110461A
Other languages
Spanish (es)
Inventor
Bruce Acres
Berangere Marie-Bastien
Original Assignee
Smithkline Beecham Corp
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp, Transgene Sa filed Critical Smithkline Beecham Corp
Publication of CR20110461A publication Critical patent/CR20110461A/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención es en el campo de la inmunoterapia y se refiere a métodos para determinar la eficacia de ciertos tratamientos de inmunoterapia. los métodos de la invención incluyen medir un biomarcador especial en algún momento después de la iniciación del tratamiento de inmunoterapia para evaluar el resultado clínico del citado tratamiento. La invención tiene por consiguiente aplicaciones al campo de la medicina.The present invention is in the field of immunotherapy and refers to methods for determining the efficacy of certain immunotherapy treatments. The methods of the invention include measuring a special biomarker at some time after the initiation of immunotherapy treatment to evaluate the clinical outcome of said treatment. The invention therefore has applications in the field of medicine.

CR20110461A 2009-03-24 2011-08-26 BIOMARCATOR FOR PATIENT MONITORING CR20110461A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0993052561 2009-03-24

Publications (1)

Publication Number Publication Date
CR20110461A true CR20110461A (en) 2012-01-06

Family

ID=48407310

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20110461A CR20110461A (en) 2009-03-24 2011-08-26 BIOMARCATOR FOR PATIENT MONITORING

Country Status (1)

Country Link
CR (1) CR20110461A (en)

Similar Documents

Publication Publication Date Title
TR201904638T4 (en) Evaluation, analysis and treatment of pKal-mediated disorders.
EA201490230A1 (en) USE OF SWINDLE HSP90 INHIBITORS
ECSP12012024A (en) COMBINED THERAPY FOR CANCER TREATMENT AND RELATED DIAGNOSTIC TESTS
AR098155A1 (en) METHODS TO DIAGNOSTIC AND TREAT EOSYNOPHYL DISORDERS
MY188365A (en) Diagnosis and treatments relating to th2 inhibition
MX358517B (en) Methods for determining drug efficacy using cereblon-associated proteins.
CR20110066A (en) MONOCLONAL ANTIBODIES AGAINST THE INHIBITING TISSULAR FACTOR OF THE VIA
ECSP13012913A (en) MONOCLONAL ANTIBODIES AGAINST THE INHIBITOR OF THE TISSULAR FACTOR ROUTE (TFPI)
MY174894A (en) Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation
DOP2015000070A (en) PROCEDURES FOR MANUFACTURING USEFUL DRUGS TO TREAT REUMATOID ARTHRITIS
CO2017002400A2 (en) Compositions and methods for detection of smn protein in a subject
SMT201600412B (en) METHODS FOR DIABETES TREATMENT WITH ANTAGONISTS OF DLL4
CY1120094T1 (en) PHARMACEUTICAL COMPOSITION INCLUDING DESPR036 EXPANDH-4 (1-39) -LYS6-NH2 FOR USE IN THE TREATMENT OF A NEUROCOLOGICAL PATIENT
GT201200252A (en) OPTIMIZED MONOCLONAL ANTIBODIES AGAINST THE INHIBITOR OF THE TISSULAR FACTOR ROUTE (TFPI)
EA201790444A1 (en) HSP90-directed visualization and inflammation therapy and infection
CO2017007383A2 (en) Methods for using antisense oligonucleotides for smad7
CR20140400A (en) COMBINED THERAPY FOR THE TREATMENT OF OVARIO CANCER
CO6592030A2 (en) Use of ventricular dilation rate in the treatment of Alzheimer's disease with intravenous immunoglobulin
CY1119413T1 (en) METHOD FOR PRODUCTION AND USE OF A COPYMOBLE Sodium CARBOSYMYTHYLOCYTLERINE AND GOSYPOLIS
BR112014011488A2 (en) medicine for therapeutic treatment and / or improvement of sepsis
CO6440591A2 (en) BIOMARCARDOR TO MONITOR PATIENTS
BR112017004883A2 (en) rgma fragment-based diagnostic assay
BR112015005583A2 (en) Method for diagnosing a molecular phenotype of a patient suffering from a disease associated with chronic inflammation
CO6450670A2 (en) BIOMARCATOR TO MONITOR PATIENTS
BR112014000670A2 (en) use of oligosaccharide compounds for the prevention and treatment of pathological scars